Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

Highest Quality | For Research Use Only

Buy DSIP Peptide France

Delta Sleep-Inducing Peptide (DSIP), a nonapeptide, is believed to function by modulating the body’s sleep patterns. The exact mechanism of DSIP’s function remains an active area of France research, but it is believed to be involved in somnogenic and sedative actions, possibly through modulation of the GABAergic system or interaction with adenosine receptors. DSIP peptide is also thought to have a role in modulating the body’s response to stress and homeostasis of bodily processes.

The benefits of DSIP are primarily centered around its sleep-enhancing properties. France Research has shown that DSIP can increase SWS (slow wave sleep) and REM sleep while reducing wakefulness. This makes it effective for cognitive functioning and potentially useful for treating sleep disorders such as insomnia. Additionally, DSIP has been found to exhibit anti-stress effects, possibly due to its ability to normalize the body’s response to stressors.

Moreover, DSIP has been observed to have an influence on endocrine systems. It has been associated with regulation of corticotropin-releasing hormone (CRH) levels, and thus, may have potential in managing diseases associated with CRH dysfunction.

Showing all 3 results

Potential Benefits of DSIP Peptide

  • Sleep Regulation: Delta sleep-inducing peptide (DSIP) has been shown in studies to regulate sleep patterns, potentially offering therapeutic benefits for individuals with sleep disorders [1].
  • Potential Therapeutic Benefit in Stroke Recovery: A study demonstrated that DSIP peptide might have potential therapeutic benefits in stroke therapy, specifically in accelerating the recovery of motor functions after a stroke [2].
  • Anti-Epileptic Effects: Research suggests that the interaction of DSIP with certain drugs, like valproate, can enhance their anti-epileptic effects, potentially providing additional benefits in managing epileptic seizures [3].
  • Influence on Electroencephalogram (EEG): DSIP has been observed in research to influence EEG and power spectra in rats, which could potentially be used to study its effects on brain activity and sleep regulation [4].
  • Potential Role in Chronic Inflammation: Studies indicates that DSIP peptide may play a role in managing chronic inflammation, particularly in conditions such as end-stage renal disease and dialysis [5].
  • Expression and Purification in Pichia pastoris: The yeast Pichia pastoris has been used for the expression of DSIP fusion protein. This approach combines the benefits of Escherichia coli expression (cost-effectiveness and easy scale-up) with the advantages of eukaryotic expression systems, potentially aiding in the large-scale production of DSIP [6].
  • Presence in Human Milk: DSIP is one of the bioactive peptides found in human milk, suggesting its potential role in infant nutrition and development [7].

References

[1] https://pubmed.ncbi.nlm.nih.gov/6145137/

[2] https://www.mdpi.com/ 1420-3049/26/17/5173

[3] https://pubmed.ncbi.nlm.nih.gov/17957464/

[4] https://pubmed.ncbi.nlm.nih.gov/11214497/

[5] https://pubmed.ncbi.nlm.nih.gov/30281126/

[6] https://pubmed.ncbi.nlm.nih.gov/28462721/

[7] https://pubmed.ncbi.nlm.nih.gov/3909780/

DISCLAIMER: We do not supply peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (https://france.direct-peptides.com) and provided through Direct Peptides are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.